The Rising Prevalence Of Erectile Dysfunction (ED) To Boost The Human Chorionic Gonadotropin (HCG) Market Growth

 

Human Chorionic Gonadotropin (HCG) Market

Human Chorionic Gonadotropin (HCG) Market is Segmented by Product (Naturally Extracted and Recombinant), Application (Male Hypogonadism, Female Infertility Treatment, Oligospermic Treatment, and Other Applications), By End User (Ambulatory Surgical Centers , Hospitals and Specialty Clinics) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2023– 2030

Global Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at US$ 710.88 Million in 2022 and is expected to exhibit a CAGR of 6.5% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Human Chorionic Gonadotropin is a hormone generated by a women during pregnancy. It is produced in placenta. It is often known as the pregnancy hormone due to its ideal role in assisting a pregnancy. Human chorionic gonadotrophin is seen in the urine or blood for over 10 to 11 days post conception. The Human chorionic gonadotrophin levels are high towards the last of the first trimester, further waning for the rest of the gravidness. 

Competitive Landscape:

Key players involved in the growth of global Human Chorionic Gonadotropin (HCG) Market are Merck & Co. Inc., Merck KGaA, Lupin Limited, Sanzyme, and Fresenius SE & Co. KGaA.

Market Key Drivers:

The rising prevalence of erectile dysfunction (ED) is expected to augment the growth of global Human Chorionic Gonadotropin (HCG) Market. For instance, as per BMC Endocrine disease in July 2021, erectile dysfunction (ED) was reported to be high in around 72.2% of people across the globe.

The rising prevalence of infertility in women is also projected to propel the growth of global Human Chorionic Gonadotropin (HCG) Market. For instance, as per CDC, March 2022, around 22% couples in which the female is aged around 30 to 39 years have difficulty in conceiving their first child.

Covid-19 Impact Analysis:

The Covid-19 outbreak has adversely affected the growth of global Human Chorionic Gonadotropin (HCG) Market due to the surge in pandemic as there was rising shift of providers in curing the Covid-19 patients. The delay in treatment of the other disorders and rising social distance policy has impeded the market growth.

Key Takeaways:

The global Human Chorionic Gonadotropin (HCG) Market is anticipated to exhibit a CAGR of 7 % during the forecast period owing to the rising infertility in women. For instance, as per NLM in December 2021, the total cases of infertility was around 24.58%, with 6.54% of female experiencing first infertility.

Among regions, North America, Europe and Asia Pacific are expected to witness robust growth in global Human Chorionic Gonadotropin (HCG) Market due to increasing cases of infertility, rising healthcare infrastructure, increasing reimbursement policies and increasing adoption of ART. For instance, as per CDC, in U.S, around 11% of female and 9% of male of childbearing age have infertility problems.

Comments

Popular posts from this blog

Forging has significant application in creation of various metal for wide range of applications

Ginseng Market Outlook, Analysis and forecast up to 2028

The Vaccine Contract Manufacturing Industry to Flourish Due to Urgent Need to Develop Reliable and Cost-Effective Vaccines against Covid-19